Po-Yuan Chen1, Chih-Chien Tsai1, Chin-Song Lu2, Yi-Hsin Weng2, Yi-Ming Wu3, and Jiun-Jie Wang1
1Chang Gung University, Taoyuan, Taiwan, 2Chang Gung Memorial Hospital, Taoyuan, Taoyuan, Taiwan, 3Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan
Synopsis
Precise differentiation between MSA subtype is critical
in medical intervention and prognosis. The results of previous studies using
DTI to differentiate subtypes of MSA is controversial. We use fixel based
analysis to examine the tract-specific differences in white matter between individuals
with MSA and healthy controls. The results demonstrate the white matter
degeneration in specific fibre bundle, including middle cerebellar peduncle,
pontine crossing tract and cerebellar white matter tracts in the early MSA-C
patients; in contrast, this pattern was not observed in MSA-P patients. This
suggests that FBA may be a sensitive marker for early differential diagnosis of
MSA subtype.
Introduction
Multiple system atrophy (MSA) is a rare, fatal
neurodegenerative disorder with autonomic impairment plus predominantly
levodopa-refractory parkinsonism (in the parkinsonian subtype, MSA-P) or cerebellar
syndrome (in the cerebellar subtype, MSA-C).1,2 Precise differentiation among two subtypes
is challenging because of the overlap both in clinical and histopathological.3,4
Medication strategies and prognosis vary with the subtype of the disease.5,6
Thus, an objective diagnostic biomarker is crucial for disease-modifying
therapy. However,
previous studies using diffusion tensor imaging for the differentiation of
subtype of MSA is debated.7-9
Fixel
Based analysis (FBA) is a novel framework that provides fibre-specific
comparison in the white matter (WM). FBA can be used to analyze distinct fiber
populations within a voxel (termed “fixels”).10 FBA is capable of
evaluating multiple fibre bundles within a voxel and enables the assessment of
both micro-structural (intra-axonal fibre volume, Fibre Density) and macro-structural
(fibre bundle width, Fibre Cross-section) changes in the white matter.10
The different pattern of WM
degeneration could be observed between subtypes in the earlier stage in
patients with MSA.7 Thus, the study aimed to determine the white
matter differences by FBA in patients with MSA, especially between MSA-P and
MSA-C. Patients with MSA were further divided into the group with long (> 3
years) and short (≦ 3 years) disease duration to examine whether the
different pattern of WM degeneration was detected in an earlier stage.Methods
Image Acquisition
Image
were acquired from 40 probable MSA patients and 40 age and gender-matched healthy
control subjects using a 3T MR scanner (Magnetom Trio, Erlangen, Siemens,
Germany). Diffusion-weighted images were acquired with spin-echo echo-planar
imaging (SE-EPI) sequence and three different imaging protocols. Forty slices were
acquired to cover the brain. Two diffusion weighting values (b-values) – 0 and
1000 sec/mm2- were used in the analysis. A T1-weighted images were
acquired with magnetization prepared rapid acquisition gradient echo
(T1-MPRAGE) sequence (160 axial slices; voxel size 1 mm x 1 mm x1 mm; TR/TE=
2000 ms/2.63 ms; flip angle= 9°;
field of view= 224 mm x 256 mm) was also obtained from each subject. The demographic data and
imaging parameters were listed in Table 1.
Fixel Based Analysis
FBA
was performed using the MRtrix3 according to recommended procedures.10
Diffusion data underwent preprocessing, including denoising, Gibbs
ringing removal, motion and distortion correction, bias field correction.10
A study-specific template was generated, to which all subjects and subsequent image
data were registered to. Single-tissue constraint spherical deconvolution (CSD)
was used for computing fibre density (FD) and fibre cross-section (FC) with
fibre orientation distributions (FODs).11A combined index fibre
density and cross-section (FDC) was calculated by multiplying FD and FC.10
Statistical analysis
Family-wise error (FWE)-corrected
p-values were assigned to each fixel with nonparametric permutation testing
and connectivity-based fixel enhancement (CFE).12 Significance was
denoted by FWE-corrected p-value <
0.05. To visualize the findings, significant fixels were then displayed using
mrview tool in MRtrix3.
Results
Figure
1 showed significant changes in FD (upper row), FC (middle row) and FDC (lower
row) from patients with MSA compared with healthy controls. The main reduction of fixels were identified in
the middle cerebellar peduncle, pontine crossing tract, bilateral cerebral
peduncle, superior cerebellar peduncle, internal capsule and corticospinal
tract. Significant FC increase was identified in the fornix.
The difference of
white matter degeneration between subtype in patients with disease duration≦3 years and > 3 years was shown in
figure 2. In the patients with disease duration≦3
years, FC and FDC of middle cerebellar peduncle, pontine crossing tract and
cerebellar white matter tracts were significantly decreased in MSA-C.
Furthermore, FD of MSA-P demonstrated extensive FD loss compared to MSA-C in
patients with disease duration > 3 years.
The Difference of white matter between
subtype in FC was represented in figure 3. No difference was observed in all
three groups of MSA patients with disease duration ≦3 years; however, fixels of fornix were
significantly increased in the group of MSA(All) and MSA-P with disease
duration > 3 years.Discussion
Our results demonstrate distinct pattern of
white matter degeneration between MSA subtypes. The regions of fixels with
significant change were congruent with the locations of white matter lesion
reported by DTI literature.13-15 In early MSA, MSA-C was detected to
have more WM involvement in comparison to MSA-P. This result endorse previous
DTI findings.7
To our surprise, the FC of fornix was significantly
increased compared to healthy controls. This phenomenon accompany with disease
progression and exist only in MSA-P subtype. Previous literature16
indicates other cell death mechanisms besides apoptosis might responsible for
neuronal death in MSA. Previous study report necroptosis, which is a regulated
necrosis and characterized by cell swelling, play an important role in pathogenesis
of Parkinson’s disease17. Since both MSA and Parkinson’s Disease are
classified as “α-Synucleinopathies”.18 The increase of fibre bundle
width of fornix might owing to the necroptosis-induced cell swelling. Widespread
FD loss together with significant FC increase in fornix, which exclusive exist
in late MSA-P suggest the possibility of worse survival in MSA-P as reported by
previous literature.2,5Conclusion
Our findings indicate FBA may serve as a biomarker for early differential diagnosis of MSA. It can potentially aid in treatment efficacy, and consequently increased quality of
life of patients.Acknowledgements
No acknowledgement found.References
1. Wenning GK, Tison F, Ben Shlomo Y, et al. Multiple system
atrophy: a review of 203 pathologically proven cases. Mov Disord. 1997;12(2):133-147.
2. Gilman S, Wenning GK, Low
PA, et al. Second consensus statement on the diagnosis of multiple system
atrophy. Neurology. 2008;71(9):670-676.
3. Roncevic D, Palma JA, Martinez
J, et al. Cerebellar and parkinsonian phenotypes in multiple system atrophy:
similarities, differences and survival. J Neural Transm. 2014;121(5):507-512.
4. Watanabe H, Riku Y, Hara K, et al. Clinical and Imaging
Features of Multiple System Atrophy: Challenges for an Early and Clinically
Definitive Diagnosis. J Mov Disord. 2018;11(3):107-120.
5. Wenning GK, Geser F, Krismer F, et al. European Multiple System Atrophy
Study Group. The natural history of multiple system atrophy: a prospective
European cohort study. Lancet Neurol. 2013;12(3):264-274.
6. Chelban V, Catereniuc
D, Aftene D, et al. An update on MSA: premotor and non-motor features open a
window of opportunities for early diagnosis and intervention. J Neurol. 2020;267(9):2754-2770.
7. Dash
SK, Stezin A, Takalkar T, George L, Kamble NL, Netravathi M, Yadav R, Kumar KJ,
Ingalhalikar M, Saini J, Pal PK. Abnormalities of white and grey matter in
early multiple system atrophy: comparison of parkinsonian and cerebellar
variants. Eur Radiol. 2019;29(2):716-724.
8. Li J,
Donglin Z, Chaoyong X, et al. Tract based spatial statistics in multiple system
atrophy: A comparison between clinical subtypes. Parkinsonism & Related
Disorders. 2014;20(10):1050-1055.
9. Rulseh AM, Keller J, Rusz J, et al.
Diffusion tensor imaging in the characterization of multiple system atrophy.
Neuropsychiatr Dis Treat. 2016;26(12):2181-2187.
10. Raffelt
DA, Tournier JD, Smith RE, et al. Investigating white matter fibre density and
morphology using fixel-based analysis. Neuroimage. 2017;144(Pt A):58-73.
11. Raffelt
D, Tournier JD, Rose S, et al. Apparent Fibre Density: a novel measure for the
analysis of diffusion-weighted magnetic resonance images. Neuroimage.
2012;59(4):3976-3994.
12. Raffelt
DA, Smith RE, Ridgway GR, et al. Connectivity-based fixel enhancement:
Whole-brain statistical analysis of diffusion MRI measures in the presence of
crossing fibres. Neuroimage. 2015;15(117):40-55.
13. Oishi K, Konishi J, Mori S, et al. Reduced
fractional anisotropy in early-stage cerebellar variant of multiple system
atrophy. J Neuroimaging. 2009;19:127–131.
14. Wang PS, Wu HM, Lin CP, et al. Use of
diffusion tensor imaging to identify similarities and differences between
cerebellar and Parkinsonism forms of multiple system atrophy. Neuroradiology. 2011;53:471–481.
15. Wang PS, Yeh CL, Lu CF, et al. The
involvement of supratentorial white matter in multiple system atrophy: a
diffusion tensor imaging tractography study. Acta Neurol Belg. 2016;117:213–220.
16. Probst-Cousin S, Rickert CH, Schmid KW, et
al. Cell death mechanisms in multiple system atrophy. J Neuropathol Exp Neurol.
1998;57(9):814-821.
17. Wu JR, Wang J, Zhou SK, et al.
Necrostatin-1 protection of dopaminergic neurons. Neural Regen Res. 2015;10(7):1120-1124.
18. Wakabayashi K, Yoshimoto M, Tsuji S, et al.
Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple
system atrophy. Neurosci Lett. 1998;249(2-3):180-182.